Presentationer
2024
- CSO/CMO Anna Frostegård presenting at Redeye Technology & Life Science day, 3 December 2024 (eng)
- CEO Anders Haegerstrand presenting at BioStock Life Science Summit in Lund, 21 November 2024 (eng)
- CEO Anders Haegerstrand presenterar på Redeye Investor forum i Göteborg, 7 november 2024 (swe)
- Biostock Vator Securities event – 5 min CEO interview with Anders Haegerstrand, 12 September 2024 (eng)
- Biostock Vator Securities Event – Investing in Life Science 2024 – From Seed to Success, 12 September 2024
- Biostock interview on topline data with our CEO Anders Haegerstrand & CSO/CMO Anna Frostegård, 27 August 2024
- Interview at Redeye on topline data with our CEO Anders Haegerstrand & CSO/CMO Anna Frostegård, 22 August 2024
- CEO Anders Haegerstrand & CSO/CMO Anna Frostegård presenterar på Redeye Growth Day 2024, 31 maj 2024
- CSO/CMO Anna Frostegård presenterar hos Redeye, 16 maj 2024
- CSO/CMO Anna Frostegård & CEO Anders Haegerstrand intervju om sista patienten behandlad i Annexins RVO studie – lovande effektsignaler och inga säkerhetsproblem, 29 april 2024
